Can low thyroid hormone signaling impair ovarian function and reduce fertility even with regular menstrual cycles?

Thyroid hormones are essential regulators of the female reproductive system. Evidence confirms they act directly on the ovaries to modulate follicular development, steroidogenesis, and oocyte quality. Even in the absence of overt menstrual irregularities, subtle deficiencies in thyroid signaling—often referred to as subclinical hypothyroidism or thyroid autoimmunity—can significantly impair fertility and pregnancy outcomes.

Mechanistic explanations

Thyroid hormones, specifically triiodothyronine (T3), exert direct effects on ovarian tissue through receptors located on granulosa cells and oocytes.

• Synergy with Gonadotropins: T3 synergizes with follicle-stimulating hormone (FSH) to upregulate the expression of the FSH receptor and key enzymes like aromatase (CYP19A1). This enhances the production of estradiol, which is critical for follicle maturation.
• Folliculogenesis and Survival: Low thyroid signaling leads to the downregulation of genes essential for steroidogenesis and oocyte maturation. It also triggers endoplasmic reticulum stress in granulosa cells, increasing markers of apoptosis (such as cleaved caspase-3), which results in follicle atresia and a reduced ovarian reserve.
• Implantation Support: Beyond the ovary, adequate thyroid signaling is necessary to maintain an optimal uterine environment. Research indicates that thyroid hormones help regulate the "uterine milieu," supporting successful embryo implantation.

Clinical and effectiveness evidence

Clinical data demonstrate that thyroid dysfunction can compromise fertility even when ovulation and menstruation appear normal.

• Ovarian Reserve Metrics: Meta-analyses of patients with subclinical hypothyroidism show significantly lower levels of Anti-Müllerian Hormone (AMH) and reduced antral follicle counts (AFC) compared to euthyroid controls, indicating a decline in follicular quantity and quality.
• Assisted Reproduction Outcomes: In women with regular cycles undergoing IVF, thyroid autoimmunity (TAI) is associated with a 28% reduction in embryo implantation rates (OR 0.72) and a 27% decrease in live birth rates (OR 0.73).
• Thresholds for Conception: TSH levels above 2.98 mIU/mL have been linked to reduced oocyte maturation rates. Consequently, guidelines from organizations like the American Thyroid Association (ATA) often recommend optimizing TSH to below 2.5 mIU/L for women seeking to conceive.

Bottom line

Low thyroid hormone signaling impairs fertility by reducing gonadotropin sensitivity, increasing follicle cell death, and compromising the uterine environment. These effects can occur in "subclinical" states, meaning fertility can be significantly reduced even when menstrual cycles remain regular and TSH levels fall within the traditional "normal" range.